Pharmacological and functional biochemical properties of D-Ala 2-D-Nle5-enkephalin-Arg-Phe

Regulatory Peptides

Volumn 122, Issue 2, 2004, Pages 139-146

  Tóth, Fanni ^a   Horváth, Gyöngyi ^b   Szikszay, Margit ^b   Farkas, Judit ^a   Tóth, Géza ^a   Borsodi, Anna ^a   Benyhe, Sándor ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

CHO cells; Enkephalins; G protein stimulation; Opioid receptor; Radioligand binding; Tail withdrawal

Indexed keywords

APROTININ; BACITRACIN; CYPRODIME; DELTA OPIATE RECEPTOR; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); KAPPA OPIATE RECEPTOR; METENKEPHALIN DERIVATIVE; METENKEPHALIN[2 DEXTRO ALANINE 6 ARGININE 7 PHENYLALANINE]; METENKEPHALIN[6 ARGININE 7 PHENYLALANINE]; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR ANTAGONIST; NALOXONE; NALTRINDOLE; NORBINALTORPHIMINE; TYROSYL DEXTRO ALANYLGLYCYLPHENYLALANYL DEXTRO NORLEUCYLARGINYLPHENYLALANINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BIOCHEMISTRY; BRAIN MEMBRANE; CHO CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; HOMOGENATE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; RADIOASSAY; RAT; SPINAL CORD;

ANIMALS; BINDING, COMPETITIVE; CELL MEMBRANE; CHO CELLS; CRICETINAE; ENKEPHALINS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HEAT; INHIBITORY CONCENTRATION 50; RATS; RATS, WISTAR; RECEPTORS, OPIOID; SPINAL CORD; STRESS; TAIL; TIME FACTORS; WATER;

CRICETINAE; CRICETULUS GRISEUS;

EID: 4544278750     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2004.06.017     Document Type: Article

References (43)

1. Nakanishi S., Inoue A., Kita T., Nakamura M., Chang A.C.Y., Cohen S.N., et al. Nucleotide sequence of cloned cDNA for bovine corticotropin-beta- lipotropin precursor. Nature. 278:1979;423-427
2. Kakidani H., Furutani Y., Takahashi H., Noda M., Morimoto Y., Hirose T., et al. Cloning and sequence analysis of cDNA for porcine beta-neoendorphin/ dynorphin precursor. Nature. 298:1982;245-249
3. Noda M., Furutani Y., Takahashi H., Toyosato M., Hirose T., Inayama S., et al. Cloning and sequence analysis of cDNA for bovine adrenal proenkephalin. Nature. 295:1982;202-206
4. Mollereau C., Simons M.J., Soularue P., Liners F., Vassart G., Meunier J.C., et al. Structure, tissue distribution, and chromosomal localization of the prepronociceptin gene. Proc. Natl. Acad. Sci. U. S. A. 93:1996;8666-8670
5. Kilpatrick D.L., Howells R.D., Lahm H.W., Udenfriend S. Evidence for a proenkephalin-like precursor in amphibian brain. Proc. Natl. Acad. Sci. U. S. A. 80:1983;5772-5775
6. Gonzalez N.V., Gonzalez S.R., Rodriguez R.E. Characterization of zebrafish proenkephalin reveals novel opioid sequences. Brain Res. Mol. Brain Res. 114:2003;31-39
7. 7. Proc. Natl. Acad. Sci. U. S. A. 77:1980;5512-5514
8. 7 in mice. Eur. J. Pharmacol. 253:1994;293-296
9. 7. Nature. 298:1982;275-276
10. 7, an endogenous neuropeptide, binds to multiple opioid and nonopioid sites in rat brain. J. Neurosci. Res. 48:1997;249-258
11. 7 binding to multiple sites in rat and guinea pig cerebellum. Life Sci. 64:1999;1189-1196
12. 7 derived peptides. Life Sci. 66:2000;1241-1251
13. 3H]Tyr-D-Ala-Gly-Phe-D-Nle-Arg-Phe. Peptides. 24:2003;1433-1440
14. 7 binding to opioid receptors in frog brain membrane preparations. J. Neurochem. 63:1994;1460-1465
15. Schmidhammer H., Burkard W.P., Eggstein-Aeppli L., Smith C.F. Synthesis and biological evaluation of 14-alkoxymorphinans: 2. (-)-N-(cyclopropylmethyl)- 4,14-dimethoxymorphinan-6-one, a selective mu opioid receptor antagonist. J. Med. Chem. 32:1989;418-421
16. Portoghese P.S., Lipkowski A.W., Takemori A.E. Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists. Life Sci. 40:1987;1287-1292
17. Yaksh T.L., Rudy T.A. Chronic catheterization of the spinal subarachnoid space. Physiol. Behav. 17:1976;1031-1036
18. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1986;248-254
19. Leatherbarrow R.J. Grafit version 3.0. 1992;1-287 Erithacus Software, Staines (UK)
20. Stannard P., Platt M., Pilkington J. GraphPad Prism 2.01. 1995;1-373 GraphPad Softwares, San Diego (USA)
21. Spetea M., Monory K., Tömböly Cs., Tóth G., Tzavara E., Benyhe S., et al. In vitro binding and signaling profile of the novel μ-opioid receptor agonist endomorphin-2 in rat brain membranes. Biochem. Biophys. Res. Commun. 250:1998;720-725
22. Kramer T.H., Shook J.E., Kazmierski W., Ayres E.A., Wire W.S., Hruby V.J., et al. Novel peptidic mu opioid antagonists: pharmacologic characterization in vitro and in vivo. J. Pharmacol. Exp. Ther. 249:1989;544-551
23. 3H]TIPP. Life Sci. 53:1993;PL57-PL62
24. Roemer D., Buescher H.H., Hill R.C., Pless J., Bauer W., Cardinaux F., et al. A synthetic enkephalin analogue with prolonged parenteral and oral analgesic activity. Nature. 268:1977;547-549
25. Zajac J.M., Gacel G., Petit F., Dodey P., Rossignol P., Roques B.P. Deltakephalin, Tyr-D-Thr-Gly-Phe-Leu-Thr: a new highly potent and fully specific agonist for opiate delta-receptors. Biochem. Biophys. Res. Commun. 111:1983;390-397
26. Story S.C., Murray T.F., Delander G.E., Aldrich J.V. Synthesis and opioid activity of 2-substituted dynorphin A-(1-13) amide analogues. Int. J. Pept. Protein Res. 40:1992;89-96
27. Horváth G., Szikszay M., Benedek G. Antinociceptive effects of endomorphin-1 and -2 in rat. Life Sci. 65:1999;2635-2641
28. Joó G., Horváth G., Klimscha W., Kékesi G., Dobos I., Szikszay M., et al. The effects of ketamine and its enantiomers on the morphine- or dexmedetomidine-induced antinociception after intrathecal administration in rats. Anesthesiology. 93:2000;231-241
29. Horváth G. Endomorphin-1 and endomorphin-2. Pharmacology of the selective endogenous μ-opioid receptor agonists. Pharmacol. Ther. 88:2000;437-463
30. 35S]GTPgammaS binding assays. Eur. J. Pharmacol. 383:1999;209-214
31. 3H]Tyr-D-Ala- Phe-Phe-NH2 with mu-opioid receptor in rat brain and CHO-mu/1 cell line. Peptides. 19:1998;1091-1098
32. 3H]-dermorphin in the rat brain. Int. J. Pept. Protein Res. 32:1988;506-511
33. Reddy P.L., Bhargava H.N. Effect of low pH treatment on opioid peptides binding to their receptors and functional coupling of G-proteins to adenylyl cyclase in the rat spinal cord. Peptides. 17:1996;625-628
34. Zhao G.M., Qian X., Schiller P.W., Szeto H.H. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at μ, δ, and κ opioid receptors. J. Pharmacol. Exp. Ther. 307:2003;947-954
35. Kieffer B.L. Recent advances in molecular recognition and signal transduction of active peptides: receptors for opioid peptides. Cell. Mol. Neurobiol. 15:1995;615-635
36. Knapp R.J., Malatynska E., Collins N., Fang L., Wang J.Y., Hruby V.J., et al. Molecular biology and pharmacology of cloned opioid receptors. FASEB J. 7:1995;516-525
37. Wang J.B., Imai Y., Eppler C.M., Gregor P., Spivak C.E., Uhl G.R. Mu opiate receptor: cDNA cloning and expression. Proc. Natl. Acad. Sci. U. S. A. 90:1993;10230-10234
38. Avidor-Reiss T., Bayewitch M., Levy R., Matus-Leibovitch N., Nevo I., Vogel Z. Adenylylcyclase supersensitization in mu-opioid receptor-transfected Chinese hamster ovary cells following chronic opioid treatment. J. Biol. Chem. 270:1995;29732-29738
39. Talmont F., Sidobre S., Demange P., Milon A., Emorine L.J. Expression and pharmacological characterization of the human mu-opioid receptor in the methylotrophic yeast Pichia pastoris. FEBS Lett. 394:1996;268-272
40. Piros E.T., Hales T.G., Evans C.J. Functional analysis of cloned opioid receptors in transfected cell lines. Neurochem. Res. 21:1996;1277-1285
41. Standifer K.M., Pasternak G.W. G proteins and opioid receptor-mediated signalling. Cell. Signal. 9:1997;237-248
42. 35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. Mol. Pharmacol. 47:1995;848-854
43. Liapakis G., Chan W.C., Papadokostaki M., Javitch J.A. Synergistic contributions of the functional groups of epinephrine to its affinity and efficacy at the β2 adrenergic receptor. Mol. Pharmacol. 65:2004;1181-1190